
Gary S Firestein MD
Distinguished Professor, Medicine, UCSD School of Medicine
Join to View Full Profile
200 W Arbor DrSan Diego, CA 92103
Phone+1 858-822-0480
Fax+1 858-534-2606
Dr. Firestein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of California (San Diego) Medical CenterFellowship, Rheumatology, 1983 - 1986
- UCLA David Geffen School of Medicine/UCLA Medical CenterInternship, Internal Medicine, 1980 - 1981
- Johns Hopkins University School of MedicineClass of 1980
Certifications & Licensure
- CA State Medical License 1982 - 2027
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Elected member American Association for the Advancement of Science (AAAS), 2021
- Elected Master American College of Rheumatology, 2021
- Elected member Association of American Physicians, 2002
- Join now to see all
Publications & Presentations
PubMed
- Deep immunophenotyping reveals circulating activated lymphocytes in individuals at risk for rheumatoid arthritis.Jun Inamo, Joshua Keegan, Alec Griffith, Tusharkanti Ghosh, Alice Horisberger
The Journal of Clinical Investigation. 2025-03-17 - Systemic inflammation and lymphocyte activation precede rheumatoid arthritis.Ziyuan He, Marla C Glass, Pravina Venkatesan, Marie L Feser, Leander Lazaro
Biorxiv. 2024-11-12 - 8 citationsDistinct mucosal endotypes as initiators and drivers of rheumatoid arthritis.V Michael Holers, Kristen M Demoruelle, Jane H Buckner, Eddie A James, Gary S Firestein
Nature Reviews. Rheumatology. 2024-10-01
Journal Articles
- Reply to Letter to the EditorGary L Simon, Gary S Firestein, Aileen Y Chang, Arthritis & Rheumatology
- Reply to Comments on “The Frequency of Chronic Joint Pain Following Chikungunya Virus Infection A Colombian Cohort Study”Gary S Firestein, Gary L Simon, Aileen Y Chang, Arthritis & Rheumatology
- Methods for High-Dimensonal Analysis of Cells Dissociated from Cyropreserved Synovial TissuePaul J Utz, William H Robinson, Ellen M Gravallese, Soumya Raychaudhuri, Alessandra B Pernis, Susan M Goodman, Michael B Brenner, Lionel B Ivashkiv, Brendan F Boyce, P..., BioMed Central
Lectures
- American College of Rheumatology (ACR): Winter Rheumatology SymposiumAmerican College of Rheumatology(ACR), Snowmass, Colorado - 1/26/2013
Other
- Pathogenesis of rheumatoid arthritisFirestein GS, Schur PH
http://www.uptodate.com/contents/pathogenesis-of-rheumatoid-arthritis
UpToDate, Wolters Kluwer Health - 2012-09-11
Press Mentions
- Novel Study Identifies Key Molecular Players in Rheumatoid ArthritisOctober 23rd, 2022
- UCSD Gets $3 Million to Reduce Latino Childhood ObesityJuly 7th, 2021
- In-Depth: The Flaw with U.S. Efforts to Track Coronavirus VariantsMay 25th, 2021
- Join now to see all
Grant Support
- Rheumatic Diseases Research Training GrantUNIVERSITY OF CALIFORNIA, SAN DIEGO2013–2029
- Methotrexate treatment of Arthritis caused by Chikungunya virus (MARCH): A randomized controlled trial of methotrexate versus placebo in the treatment of chronic arthritis after chikungunya infectionGEORGE WASHINGTON UNIVERSITY2022–2027
- Methotrexate treatment of Arthritis caused by Chikungunya virus (MARCH): A randomized controlled trial of methotrexate versus placebo in the treatment of chronic arthritis after chikungunya infectionGEORGE WASHINGTON UNIVERSITY2022–2027
- Methotrexate treatment of Arthritis caused by Chikungunya virus (MARCH): A randomized controlled trial of methotrexate versus placebo in the treatment of chronic arthritis after chikungunya infectionGEORGE WASHINGTON UNIVERSITY2022–2027
- Methotrexate treatment of Arthritis caused by Chikungunya virus (MARCH): A randomized controlled trial of methotrexate versus placebo in the treatment of chronic arthritis after chikungunya infectionGEORGE WASHINGTON UNIVERSITY2022–2027
- Methotrexate treatment of Arthritis caused by Chikungunya virus (MARCH): A randomized controlled trial of methotrexate versus placebo in the treatment of chronic arthritis after chikungunya infectionGEORGE WASHINGTON UNIVERSITY2022–2027
- Methotrexate treatment of Arthritis caused by Chikungunya virus (MARCH): A randomized controlled trial of methotrexate versus placebo in the treatment of chronic arthritis after chikungunya infectionGEORGE WASHINGTON UNIVERSITY2022–2027
- Methotrexate treatment of Arthritis caused by Chikungunya virus (MARCH): A randomized controlled trial of methotrexate versus placebo in the treatment of chronic arthritis after chikungunya infectionGEORGE WASHINGTON UNIVERSITY2022–2027
- Methotrexate treatment of Arthritis caused by Chikungunya virus (MARCH): A randomized controlled trial of methotrexate versus placebo in the treatment of chronic arthritis after chikungunya infectionGEORGE WASHINGTON UNIVERSITY2022–2027
- UC San Diego Clinical and Translational Research InstituteUNIVERSITY OF CALIFORNIA, SAN DIEGO2015–2025
- UC San Diego Clinical and Translational Research InstituteUNIVERSITY OF CALIFORNIA, SAN DIEGO2015–2025
- Identification of key regulators in rheumatoid arthritisUNIVERSITY OF CALIFORNIA, SAN DIEGO2014–2025
- Regulation Of P38 And Inflammation By MAPK KinasesNational Institute Of Allergy And Infectious Diseases2006–2012
- CTSA Infrastructure For AIDS ResearchNational Center For Research Resources2011
- SAN Diego Clinical And Translational Research InstituteNational Center For Research Resources2010–2011
- CTSA Infrastructure For Pediatric ResearchNational Center For Research Resources2010–2011
- CTSA Infrastructure For Clinical TrialsNational Center For Research Resources2010–2011
- C-Jun N-Terminal Kinase And Joint Destruction In RANational Institute Of Arthritis And Musculoskeletal And Skin Diseases2008–2011
- Innate Immunity And The Ikki Complex In Rheumatoid Arthritis (RA) SynoviumNational Institute Of Allergy And Infectious Diseases2007–2011
- Training Grant In Rheumatic DiseasesNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2006–2010
- 'C-Jun N-Terminal Kinase And Joint Destruction In Ra'National Institute Of Arthritis And Musculoskeletal And Skin Diseases2002–2006
- Synovial Dysfunction Due To P53 Abnormalities In RANational Institute Of Arthritis And Musculoskeletal And Skin Diseases1997–2006
- Ikki Expression And Regulation In Rheumatoid ArthritisNational Institute Of Allergy And Infectious Diseases2004–2005
- Rheumatic DiseasesNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2001–2005
- Core--BiomarkerNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2001–2002
- Regulation Of Peripheral Inflammation By The CNSNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1999–2002
- Core--Research ResourcesNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1998–2002
- C-Jun N-Terminal Kinase And Joint Destruction In RANational Institute Of Arthritis And Musculoskeletal And Skin Diseases2001
- Dominant Negative IKK1 Gene Therapy In Rheumatoid ArthritisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2000
- Knee Synovitis In Rheumatoid Arthritis--Mechanistic Effects Of New DrugNational Center For Research Resources1999
- Conference On Pathogenesis Of Rheumatoid ArthritisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1998
- Methods Study In Rheumatoid Arthritis And Knee Synovitis/EffusionNational Center For Research Resources1998
- Apoptosis In Rheumatoid ArthritisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1996
- Cytokine Interactions In Inflammatory ArthritisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1990–1993
- Rheumatic DiseasesNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1986–1992
- Lymphokines In Rheumatoid ArthritisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1988–1991
- Immunoreactants In Rheumatic DiseasesNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1986–1989
- Rheumatic DiseasesNat Inst Of Arthritis, Diabetes, Digestive &Kidney Diseases1985
- Immunoreactants In Rheumatic DiseasesNat Inst Of Arthritis, Diabetes, Digestive &Kidney Diseases1985
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: